Cargando…

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?

(1) Background: Fecal calprotectin (FC) correlates well with colonic inflammatory activity of Crohn’s disease (CD); data about relation of FC and small bowel (SB) lesions are still contradictory. The main aim was to analyze the relationship between FC levels and SB inflammatory activity in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero-Mascarell, Cristina, Fernández-Esparrach, Gloria, Rodríguez-De Miguel, Cristina, Masamunt, Maria Carme, Rodríguez, Sonia, Rimola, Jordi, Urpí, Miguel, Casanova, Gherzon Simon, Ordás, Ingrid, Ricart, Elena, Caballol, Berta, Fernández-Clotet, Agnès, Panés, Julià, Llach, Josep, González-Suárez, Begoña
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497577/ https://www.ncbi.nlm.nih.gov/pubmed/36140627 http://dx.doi.org/10.3390/diagnostics12092226

Ejemplares similares

Predictors of bowel damage in the long-term progression of Crohn’s disease
por: Fernández-Clotet, Agnes, et al.
Publicado: (2022)

Diagnostic accuracy of artificial intelligence-aided capsule endoscopy (TOP100) in overt small bowel bleeding
por: Giordano, Antonio, et al.
Publicado: (2023)

Motorized Spiral Enteroscopy Is Effective in Patients with Prior Abdominal Surgery
por: Giordano, Antonio, et al.
Publicado: (2022)

Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease
por: Alfaro, Ignacio, et al.
Publicado: (2019)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative Colitis
por: Veny, Marisol, et al.
Publicado: (2020)

Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
por: Dotti, Isabella, et al.
Publicado: (2017)

Successful outcomes of a new combined solution of hyaluronic acid, chondroitin sulfate and poloxamer 407 for submucosal injection: animal survival study
por: Córdova, Henry, et al.
Publicado: (2019)

Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis
por: Mora-Buch, R, et al.
Publicado: (2016)

Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis
por: Planell, Núria, et al.
Publicado: (2017)

Critical importance of early introduction of prevention measures for SARS-CoV-2 infection in endoscopy units
por: Ginès, Àngels, et al.
Publicado: (2020)

Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?
por: Alvarez-Urturi, Cristina, et al.
Publicado: (2017)

Adverse events of NOTES mediastinoscopy compared to conventional video-assisted mediastinoscopy: a randomized survival study in a porcine model
por: Córdova, Henry, et al.
Publicado: (2015)

Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn’s Disease Patients
por: Corraliza, Ana M, et al.
Publicado: (2019)

A rapid calprotectin test for the diagnosis of pleural effusion
por: Casado-Rey, Pedro, et al.
Publicado: (2021)

Efficacy and safety of a combination of hyaluronic acid, chondroitin sulfate, and poloxamer 407 as a submucosal injection solution for endoscopic resection: pilot study on a swine model
por: Fernández-Esparrach, G., et al.
Publicado: (2017)

Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012)

Colon capsule endoscopy versus CT colonography in FIT-positive colorectal cancer screening subjects: a prospective randomised trial—the VICOCA study
por: González-Suárez, Begoña, et al.
Publicado: (2020)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile
por: Suarez-Carantoña, Cecilia, et al.
Publicado: (2021)

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease
por: Kennedy, Nicholas A., et al.
Publicado: (2019)

Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
por: Blanco-Prieto, Sonia, et al.
Publicado: (2015)

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
por: e Penna, Francisco Guilherme Cancela, et al.
Publicado: (2020)

Is it Time to Reevaluate Our Body Mass Index Cutoff in Body Contouring Surgery? An Assessment of the Preferred Cutoff Values to Minimize Venous Thromboembolism and Wound Complications
por: Gonzalez, Miguel, et al.
Publicado: (2023)

Can fecal calprotectin better stratify Crohn’s disease activity index?
por: Scaioli, Eleonora, et al.
Publicado: (2015)

Do We Need to Reevaluate the Body Mass Index Cutoff in Breast Reconstruction? An Assessment of the Preferred Cutoff Values to Minimize Venous Thromboembolism and Wound Complications
por: Zietowski, Maeson, et al.
Publicado: (2023)

Differentiation of fibrotic and inflammatory component of Crohn’s disease-associated strictures
por: Rimola, Jordi, et al.
Publicado: (2020)

Elastofibroma dorsi: serie de 4 casos diagnosticados en atención primaria
por: Estévez Carrera, Sandra, et al.
Publicado: (2013)

Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
por: Botana-Rial, Maribel, et al.
Publicado: (2020)

Prebiotic Peptide Bond Formation Through Amino Acid Phosphorylation. Insights from Quantum Chemical Simulations
por: Martínez-Bachs, Berta, et al.
Publicado: (2019)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Calprotectin in Cystic Fibrosis
por: Rumman, Nisreen, et al.
Publicado: (2014)

Calprotectin in Lung Diseases
por: Kotsiou, Ourania S., et al.
Publicado: (2021)

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
por: Somwaru, Alexander S., et al.
Publicado: (2019)

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
por: Li, Junrong, et al.
Publicado: (2023)

Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
por: Matuszczyk, Małgorzata, et al.
Publicado: (2022)

Diffusion-weighted imaging for evaluating inflammatory activity in Crohn’s disease: comparison with histopathology, conventional MRI activity scores, and faecal calprotectin
por: Pendsé, D. A., et al.
Publicado: (2016)

Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis
por: Revilla, Lluís, et al.
Publicado: (2021)

In vivo computer-aided diagnosis of colorectal polyps using white light endoscopy
por: García-Rodríguez, Ana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gt93j9bpalog1e02tan86u6714